Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Cord Blood Transplant”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Ended earlyNCT01300611
What this trial is testing

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation

Who this might be right for
Double Cord Blood TransplantAcute Myelogenous LeukemiaMyelodysplastic Syndrome+6 more
Tarix Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT01175785
What this trial is testing

Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Nohla Therapeutics, Inc. 15
Early research (Phase 1)Ended earlyNCT00973804
What this trial is testing

Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

Who this might be right for
LeukemiaNon-Hodgkins LymphomaHodgkins Lymphoma+2 more
National Cancer Institute (NCI) 4
Large-scale testing (Phase 3)UnknownNCT01015742
What this trial is testing

Unrelated Double Umbilical Cord Blood Units Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myeloid, Chronic
Tehran University of Medical Sciences 10
Testing effectiveness (Phase 2)Study completedNCT00067002
What this trial is testing

Randomized Double Cord Blood Transplant Study

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Myelocytic, AcuteLeukemia, Myeloid, Chronic+1 more
M.D. Anderson Cancer Center 110
Testing effectiveness (Phase 2)UnknownNCT02385955
What this trial is testing

Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients

Who this might be right for
Hematologic Malignancy
Seoul National University Hospital 39
Testing effectiveness (Phase 2)WithdrawnNCT01163201
What this trial is testing

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+14 more
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)UnknownNCT01983761
What this trial is testing

Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+4 more
Targazyme, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00514579
What this trial is testing

Adult Double Cord Blood Transplant Study

Who this might be right for
Cord Blood Stem Cell TransplantationHematologic Malignancies
Center for International Blood and Marrow Transplant Research 56
Testing effectiveness (Phase 2)Looking for participantsNCT06680661
What this trial is testing

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphatic LeukemiaChronic Myelogenous Leukemia+5 more
Leland Metheny 20
Testing effectiveness (Phase 2)Study completedNCT01471613
What this trial is testing

Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury

Who this might be right for
Spinal Cord Injury
China Spinal Cord Injury Network 16
Testing effectiveness (Phase 2)Ended earlyNCT00801931
What this trial is testing

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Who this might be right for
LeukemiaLymphomaNeuroblastoma+2 more
Columbia University 1
Testing effectiveness (Phase 2)UnknownNCT00328237
What this trial is testing

Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more
Colorado Blood Cancer Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT01554254
What this trial is testing

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Who this might be right for
Cord Blood TransplantHematologic MalignancyInherited Metabolic Disease
Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00597519
What this trial is testing

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

Who this might be right for
CancerLeukemiaMyelodysplastic Syndrome+1 more
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT01627314
What this trial is testing

The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

Who this might be right for
Hematologic Malignancies
Fate Therapeutics 62
Not applicableNo Longer AvailableNCT00423826
What this trial is testing

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01408563
What this trial is testing

Reduced Intensity Double Umbilical Cord Blood Transplantation

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMultiple Myeloma+2 more
Massachusetts General Hospital 33
Early research (Phase 1)Study completedNCT00890500
What this trial is testing

Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

Who this might be right for
Hematologic MalignanciesAllogeneic Stem Cell Transplantation
Fate Therapeutics 12
Load More Results